Federal Trade Commission sues drug 'gatekeepers' over high insulin prices
The three price benefit managers jointly administer 80% of all prescriptions in the U.S., the FTC said in the lawsuit.
FTC Chair Lina Khan welcomes companies weighing antitrust in deals, addresses critics
U.S. Federal Trade Commission Chair Lina Khan on Friday welcomed that companies are weighing antitrust considerations early ...
US FTC sues drug 'gatekeepers' over high insulin prices
The U.S. Federal Trade Commission sued the country's three largest pharmacy benefit managers on Friday, accusing them of ...
Federal Trade Commission accuses three drug middlemen of inflating insulin prices
In a lawsuit, the FTC accused Optum Rx, Caremark and Express Scripts of creating "a broken rebate system that inflated insulin drug prices, boosting PBM (prescription drug benefit managers) profits at ...
KSAT13h
Is your religious leader asking you to buy gift cards out of the blue? It’s more than likely a scam
Picture it — you open your email and find an unexpected message from your religious leader asking you to send gift cards for ...
Defendant Awarded Increased Attorney Fees Six Months After Trial Win Against FTC
Attorney Charles Hoffecker of Hotchkiss Hoffecker Peacock in Atlanta said the FTC failed to adjust its shotgun approach in ...
Trial Win Against FTC Yields Increased Attorney-Fee Award Six Months Later
The Federal Trade Commission failed to adjust its shotgun approach in aggressively pursuing claims against the client despite ...
WBAA17h
The FTC has filed a lawsuit over the artificially inflation of the price of insulin
The Federal Trade Commission alleges that pharmacy benefits managers prioritized high rebates from drug makers for insulin over lower prices for consumers, leading to inflated out-of-pocket costs.